Bob Mehr
Corporate Officer/Principal bei ISRACANN BIOSCIENCES INC.
Vermögen: 14 800 $ am 30.04.2024
Profil
Bob Mehr is currently the President & Chief Executive Officer at Pure Integrative Pharmacy and a Member at the College of Pharmacists of British Columbia.
He is also the Vice President-Natural Health Product Development at Isracann Biosciences, Inc. starting in 2022.
Previously, he was a Director at Merus Labs International, Inc. in 2011 and later became an Advisor at Mandala Capital, Inc. He received his undergraduate degree from the University of British Columbia.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
MANDALA CAPITAL INC
4,39% | 10.02.2023 | 400 000 ( 4,39% ) | 14 800 $ | 30.04.2024 |
Aktive Positionen von Bob Mehr
| Unternehmen | Position | Beginn |
|---|---|---|
| ISRACANN BIOSCIENCES INC. | Corporate Officer/Principal | 15.04.2022 |
| College of Pharmacists of British Columbia | Corporate Officer/Principal | - |
| Pure Integrative Pharmacy | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von Bob Mehr
| Unternehmen | Position | Ende |
|---|---|---|
Merus Labs International, Inc. /Old/
 Merus Labs International, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Merus Labs International, Inc. is a pharmaceutical company, which is engaged in the acquisition and licensing of legacy-branded prescription and over-the-counter pharmaceutical products. The company utilizes its expertise in the North American pharmaceutical markets and its access to capital to acquire and license niche branded products in Canada and the United States. It was founded on November 2, 2009 and is headquartered in Vancouver, Canada. | Direktor/Vorstandsmitglied | 23.12.2011 |
| MANDALA CAPITAL INC. | Corporate Officer/Principal | - |
| MERUS LABS INTERNATIONAL INC | Direktor/Vorstandsmitglied | - |
Ausbildung von Bob Mehr
| University of British Columbia | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| MANDALA CAPITAL INC. | Finance |
| ISRACANN BIOSCIENCES INC. | Process Industries |
| Private Unternehmen | 4 |
|---|---|
Merus Labs International, Inc. /Old/
Merus Labs International, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Merus Labs International, Inc. is a pharmaceutical company, which is engaged in the acquisition and licensing of legacy-branded prescription and over-the-counter pharmaceutical products. The company utilizes its expertise in the North American pharmaceutical markets and its access to capital to acquire and license niche branded products in Canada and the United States. It was founded on November 2, 2009 and is headquartered in Vancouver, Canada. | Health Technology |
Merus Labs International, Inc.
 Merus Labs International, Inc. Pharmaceuticals: MajorHealth Technology Merus Labs International, Inc. wass a pharmaceutical company. It was engaged in the acquisition of mature prescription and over the counter pharmaceutical products and licensing in of novel hospital products. The company was founded by Ahmad Doroudian on December 19, 2011 and it was headquartered in Vancouver, Canada. | Health Technology |
| College of Pharmacists of British Columbia | |
| Pure Integrative Pharmacy |
